GlassScriptPhysician profile
Misty R Turner
NPI 1093966202
$476.27
in general payments reported to CMS, 2019-2025
12 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $161 · 2023: $96.03 · 2024: $64.29 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.09 | 2022 | |
| Endo USA, INC. | $84.04 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $62.46 | 2023 | Xiaflex |
| Astellas Pharma US INC | $30.14 | 2025 | Xtandi |
| Axsome Therapeutics, INC. | $30.14 | 2025 | Auvelity |
| Baxter Healthcare | $22.95 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Teva Pharmaceuticals USA, INC. | $19.23 | 2025 | Uzedy |
| Paratek Pharmaceuticals, INC. | $18.16 | 2023 | Nuzyra |
| Pacira Pharmaceuticals Incorporated | $17.15 | 2025 | Exparel |
| Alkermes, INC. | $15.52 | 2024 | Vivitrol |
| Calliditas Therapeutics US INC. | $15.41 | 2023 | |
| Corcept Therapeutics | $13.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.